IMPROVING ACCESS TO 
INNOVATIVE HEALTH TECHNOLOGIES

ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies (including pharmaceuticals) in Europe.

FAQ

What is ASCERTAIN?

ASCERTAIN is a project aimed at helping people get better access to new health technologies such as medicines, medical devices, and tests. The project is creating a tool that can be used by decision-makers to understand the cost and value of these new health technologies.

What is the ASCERTAIN policy support tool?

The tool will be accessible to everyone on the internet and will have information about the cost and value of these new health technologies. It will also consider the impact on the environment. The project will work with patients, industry, policy makers, and payers to make sure the tool is good quality and useful.

Why is the affordability of innovative health technologies a challenge?

It’s a challenge for many countries in the European Union to afford new health technologies because they are often expensive and not everyone has equal access to them. This tool will help decision-makers understand how much these technologies should cost and how much they can save the healthcare system.

What are the goals of ASCERTAIN?

The goal of ASCERTAIN is to make it easier for people to understand the cost and value of new health technologies. The tool will be open to everyone and will be able to be adapted to different countries’ needs. It will have information about the cost and value of these technologies and will encourage “greener” production.

VIDEO

News

Recent site visits have highlighted the dynamic and collaborative efforts of the ASCERTAIN project in advancing precision cancer medicine (PCM) and health technology assessments (HTA) in Norway.

On April 12th, PhD student Yansi Wu presented initial findings from our Structured Expert Elicitation (SEE) project to the CONNECT group, a consortium focused on overcoming...
Read more

Greener pharmaceuticals: policies for an environmentally sustainable pharmaceutical system

The webinar on greener pharmaceuticals, hosted by the Pharmacoeconomics Department at Gesundheit Österreich, emphasized the role of pharmaceuticals in transitioning towards a planetary health approach. The event explored policy measures like health technology assessment and public procurement of medicines to promote sustainable health systems. It drew...
Read more

"Everyone is entitled to the best treatment, no matter where you live"

In many countries, patients have to wait a long time before expensive medicine become available, reducing their chance of survival. This is unfair and has to change, says professor of Health Technology Assessment Carin Uyl-de Groot at Erasmus School of Health Policy &...
Read more

Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris’s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.

Solidaris very successfully presented its bill for fair drug prices as several parties immediately...
Read more

The recent EAA Spring Convention, themed 'Finding the Right Balance,' held at Erasmus Universiteit Rotterdam, brought together industry experts and stakeholders to explore the complexities of navigating the European Union's market access for medicines and devices. Co-organized by ASCERTAIN alongside Maureen Rutten-van Mölken, Joerg Ruof, and Elaine Julian, the convention delved into key issues surrounding Health Technology Assessment...
Read more

Dear readers,

Six months have passed since our last newsletter, and a lot has happened.

In this second issue of the ASCERTAIN newsletter, we are pleased to present an interview with Maria Piggin, founder and chair of the PNH Global Alliance. Maria Piggin talks...
Read more

A catalyst for collaborative advances in cancer immunotherapy

On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting. His journey began by attending the meeting of the T2EVOLVE consortium, an EU-funded initiative pioneering collaboration between leading scientists and industry in cancer immunotherapy. This ground-breaking alliance aims to...
Read more

Navigating Challenges in Health Economics and Outcomes Research

Last week, Carin Uyl-de Groot, Mirjana Huić, Nicolas Xander and Isabelle Durand-Zaleski presented ASCERTAIN in Copenhagen. Their session was entitled: "Horizon Europe Project Ascertain: Supporting a sustainable and transparent EU HTA regulatory framework, accessibility of innovative technologies and health equity".

In this session,...
Read more

Dear Readers, 

The affordability of newly approved innovative health technologies (IHTs) is challenging in many health systems. Health care payers and health care industry across the European Union (EU) have explored different ways of defining payment for new products. ASCERTAIN addresses the need of patients, physicians, payers, regulators,...
Read more

From: iMTA NEWSLETTER September 2023

With deep sorrow we share the heartbreaking news of the loss of our dear colleague, Margreet Franken. Margreet started her professional career as a nurse, specialised in coronary and intensive care nursing. Over the years, she held various positions in hospitals located in Arnhem, Rotterdam, and Christchurch (New Zealand)....
Read more

Events

30
-
03
Jun

EuHEA Conference 2024

The EuHEA Conference 2024 in Vienna will explore how health economics can be approached from different perspectives. Its comprehensive program will feature macro analyses at the health system level, research on the decisions made by key stakeholders, and microeconomic studies on consumption and behaviours of patients and health care providers. By bringing all these perspectives together, the program aims at fostering a holistic understanding of the latest research in the field as well as informing effective, equitable, and sustainable health policies.

Join partners in Vienna!

Click here for more information.

Click here to see the program.

WATCH OUR ANIMATED VIDEO

Discover how ASCERTAIN is tackling inequalities in access to healthcare technologies with our latest animated video! Learn about the project’s mission to improve affordability and sustainability while promoting innovation and considering environmental impacts.

Contact

Please get in touch with us if you have any questions or comments! We will get back to you as soon as possible.

For research-related questions:

Carin Uyl-de Groot
Project Coordinator

Erasmus University Rotterdam
ln.rue.mphse@lyu
Phone: +31 10 4081583

For general project questions:

Marcel Langone Marques
Project Manager

Erasmus University Rotterdam
ln.rue@seuqramenognal.lecram
Phone: +31 10 4081583

For communications:

Lena Jessen
Project Manager

OptiMedis
ed.sidemitpo@nessej.l
Phone: +49 40 226211490

Our Partners